We would like to invite you to join us for the second part of our life science and medtech event on 09 November where we will continue to explore upcoming trends in IP and healthcare.
This event will highlight the increasing application of microbiome research in many commercial settings. We will also discuss the ever-important topic of performing effective due diligence in life science IP, as well as looking into the specialist areas of IP valuation, online brand enforcement and anti counterfeiting.
Speakers will include experts from EIP and Stobbs. The full schedule is available to view here.
All delegates will leave with key takeaways on the future of IP and healthcare including the risk and opportunities this emerging area offers.
Ready to learn more about the challenges faced by innovators in this exciting sector? Register here.